Recurrent hepatocellular carcinoma: Different strategies, same endpoint

Volume: 169, Issue: 4, Pages: 921 - 921
Published: Apr 1, 2021
Abstract
Hepatic resection is recommended for patients with early stage hepatocellular carcinoma (HCC) in the setting of adequate liver function and future liver remnant. However, recurrence after resection remains a significant issue, with 5-year recurrence rates upward of 60% with variations in timing of recurrence and underlying tumor biology. The mechanisms resulting in recurrent HCC may be categorized into intrahepatic metastasis versus multicentric...
Paper Details
Title
Recurrent hepatocellular carcinoma: Different strategies, same endpoint
Published Date
Apr 1, 2021
Journal
Volume
169
Issue
4
Pages
921 - 921
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.